Masimo Pre-Tax Profit Margin 2010-2023 | MASI
Current and historical pre-tax profit margin for Masimo (MASI) from 2010 to 2023. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Masimo pre-tax profit margin for the three months ending December 31, 2023 was .
| Masimo Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2023-12-31 | $2.05B | $0.09B | 4.30% |
| 2023-09-30 | $2.12B | $0.12B | 5.72% |
| 2023-06-30 | $2.19B | $0.16B | 7.27% |
| 2023-03-31 | $2.30B | $0.16B | 7.01% |
| 2022-12-31 | $2.04B | $0.19B | 9.53% |
| 2022-09-30 | $1.75B | $0.22B | 12.31% |
| 2022-06-30 | $1.50B | $0.23B | 15.36% |
| 2022-03-31 | $1.24B | $0.27B | 21.62% |
| 2021-12-31 | $1.24B | $0.28B | 22.20% |
| 2021-09-30 | $1.21B | $0.27B | 21.97% |
| 2021-06-30 | $1.18B | $0.26B | 21.92% |
| 2021-03-31 | $1.17B | $0.26B | 21.91% |
| 2020-12-31 | $1.14B | $0.26B | 23.08% |
| 2020-09-30 | $1.10B | $0.26B | 23.79% |
| 2020-06-30 | $1.05B | $0.25B | 24.24% |
| 2020-03-31 | $0.98B | $0.25B | 25.18% |
| 2019-12-31 | $0.94B | $0.23B | 24.92% |
| 2019-09-30 | $0.91B | $0.23B | 24.73% |
| 2019-06-30 | $0.90B | $0.22B | 24.78% |
| 2019-03-31 | $0.88B | $0.22B | 24.94% |
| 2018-12-31 | $0.86B | $0.22B | 25.03% |
| 2018-09-30 | $0.84B | $0.20B | 24.17% |
| 2018-06-30 | $0.83B | $0.20B | 23.85% |
| 2018-03-31 | $0.81B | $0.19B | 23.33% |
| 2017-12-31 | $0.79B | $0.19B | 23.42% |
| 2017-09-30 | $0.78B | $0.46B | 59.13% |
| 2017-06-30 | $0.76B | $0.46B | 60.16% |
| 2017-03-31 | $0.74B | $0.45B | 60.76% |
| 2016-12-31 | $0.71B | $0.43B | 60.87% |
| 2016-09-30 | $0.68B | $0.15B | 21.50% |
| 2016-06-30 | $0.66B | $0.14B | 20.63% |
| 2016-03-31 | $0.65B | $0.13B | 19.63% |
| 2015-12-31 | $0.63B | $0.12B | 18.54% |
| 2015-09-30 | $0.63B | $0.11B | 18.05% |
| 2015-06-30 | $0.62B | $0.11B | 17.50% |
| 2015-03-31 | $0.60B | $0.10B | 16.61% |
| 2014-12-31 | $0.59B | $0.10B | 17.38% |
| 2014-09-30 | $0.57B | $0.08B | 14.64% |
| 2014-06-30 | $0.55B | $0.08B | 14.62% |
| 2014-03-31 | $0.55B | $0.09B | 15.45% |
| 2013-12-31 | $0.55B | $0.08B | 13.92% |
| 2013-09-30 | $0.54B | $0.09B | 15.86% |
| 2013-06-30 | $0.52B | $0.08B | 16.03% |
| 2013-03-31 | $0.51B | $0.08B | 16.27% |
| 2012-12-31 | $0.49B | $0.08B | 17.04% |
| 2012-09-30 | $0.47B | $0.08B | 17.55% |
| 2012-06-30 | $0.46B | $0.08B | 18.12% |
| 2012-03-31 | $0.45B | $0.08B | 18.88% |
| 2011-12-31 | $0.44B | $0.09B | 20.05% |
| 2011-09-30 | $0.43B | $0.09B | 20.79% |
| 2011-06-30 | $0.43B | $0.10B | 22.09% |
| 2011-03-31 | $0.42B | $0.09B | 22.14% |
| 2010-12-31 | $0.41B | $0.11B | 26.35% |
| 2010-09-30 | $0.39B | $0.11B | 26.97% |
| 2010-06-30 | $0.38B | $0.10B | 27.18% |
| 2010-03-31 | $0.36B | $0.10B | 28.10% |
| 2009-12-31 | $0.35B | $0.08B | 23.50% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.091B | $2.048B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $219.482B | 26.59 |
| Intuitive Surgical (ISRG) | United States | $131.844B | 79.42 |
| Edwards Lifesciences (EW) | United States | $50.799B | 33.06 |
| DexCom (DXCM) | United States | $50.060B | 75.83 |
| IQVIA Holdings (IQV) | United States | $42.279B | 25.07 |
| IDEXX Laboratories (IDXX) | United States | $38.873B | 45.31 |
| Alcon (ALC) | Switzerland | $38.723B | 28.56 |
| STERIS (STE) | Ireland | $20.261B | 23.98 |
| Waters (WAT) | United States | $18.737B | 26.89 |
| Hologic (HOLX) | United States | $17.905B | 19.76 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.708B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.452B | 15.38 |
| ShockWave Medical (SWAV) | United States | $12.372B | 85.23 |
| Sysmex ADR (SSMXY) | Japan | $10.492B | 32.90 |
| Teleflex (TFX) | United States | $9.964B | 15.65 |
| Penumbra (PEN) | United States | $7.957B | 98.22 |
| Globus Medical (GMED) | United States | $6.827B | 21.64 |
| Glaukos (GKOS) | United States | $4.964B | 0.00 |
| TransMedics (TMDX) | United States | $3.847B | 367.50 |
| Integer Holdings (ITGR) | United States | $3.678B | 22.22 |
| LivaNova (LIVN) | United Kingdom | $3.391B | 20.14 |
| PROCEPT BioRobotics (PRCT) | United States | $3.115B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.700B | 18.52 |
| Nihon Kohden (NHNKY) | Japan | $2.423B | 20.49 |
| Inari Medical (NARI) | United States | $2.419B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.337B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.294B | 9.41 |
| RxSight (RXST) | United States | $2.108B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.813B | 0.00 |
| Veracyte (VCYT) | United States | $1.539B | 0.00 |
| OPKO Health (OPK) | United States | $0.885B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.868B | 16.06 |
| Artivion (AORT) | United States | $0.838B | 96.81 |
| Paragon 28 (FNA) | United States | $0.817B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.795B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.738B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.671B | 0.00 |
| SiBone (SIBN) | United States | $0.598B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.594B | 20.18 |
| IRadimed (IRMD) | United States | $0.532B | 30.88 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.487B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.460B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.420B | 0.00 |
| NeuroPace (NPCE) | United States | $0.401B | 0.00 |
| Nevro (NVRO) | United States | $0.382B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.341B | 11.47 |
| AxoGen (AXGN) | United States | $0.287B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.277B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.232B | 0.00 |
| CVRx (CVRX) | United States | $0.219B | 0.00 |
| Accuray (ARAY) | United States | $0.215B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.192B | 0.00 |
| 908 Devices (MASS) | United States | $0.187B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.184B | 9.90 |
| Alpha Tau Medical (DRTS) | Israel | $0.169B | 0.00 |
| Inogen (INGN) | United States | $0.166B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.150B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.147B | 0.00 |
| Neuronetics (STIM) | United States | $0.107B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.103B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
| Envoy Medical (COCH) | United States | $0.087B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.068B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.063B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.062B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.059B | 120.33 |
| SEP Acquisition (SEPA) | United States | $0.058B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.053B | 0.00 |
| Vasomedical (VASO) | United States | $0.050B | 9.00 |
| Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
| InspireMD (NSPR) | Israel | $0.046B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.044B | 0.00 |
| DarioHealth (DRIO) | United States | $0.043B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.040B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.040B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.038B | 0.00 |
| LENSAR (LNSR) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.025B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.022B | 0.00 |
| PAVmed (PAVM) | United States | $0.022B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |